- Home
- MDP News & Resources
- News
- Lymphatic Filariasis Eliminated in Malawi
News
Lymphatic Filariasis Eliminated in Malawi
28 October 2020 | Topics: Lymphatic Filariasis
The World Health Organization (WHO) announced in this week’s WHO Weekly Epidemiological Record that Malawi has been validated to have eliminated lymphatic filariasis as a public health problem.
In a joint press release, MSD (trade name of Merck & Co., Inc., Kenilworth, N.J., USA), GSK, and the Mectizan Donation Program congratulate President Lazarus Chakwera, the government, and the people of Malawi for this remarkable achievement that has alleviated suffering for millions and highlights the perseverance of many dedicated partners. Malawi is only the second country in sub-Saharan Africa to mark this achievement.
LF patient in Okola-Yaoundé District, Cameroon with bi-lateral LF (photo credit: William Nsai/MDP)
Warning: count(): Parameter must be an array or an object that implements Countable in /home/ntdngone/public_html/wp-content/themes/mdp-theme/single-news-resources.php on line 94
Related articles
Resources and Tools
Managing Morbidity and Preventing Disability (MMDP) Toolkit
The World Health Organization (WHO) is developing a toolkit to help programs implement MMDP services. The toolkit incorporates relevant resources developed by WHO and partner institutions, and its objectives are as follows:
provide tools and templates for implementation of key activities to strengthen delivery by the health system of the recommended minimum package of care for LF patients make information and tools accessible to national LF programs and health professionals around the world identify and resolve gaps in resourcesComponents focus on the following areas:
Planning, including patient estimation Capacity Building to Deliver MMDP Services Documentation of MMDP servicesReport
Report from the 7th Meeting of the GAELF
This report summarizes the 7th meeting of the Global Alliance to Eliminate Lymphatic Filariasis (GAELF), Washington DC, November 18-19, 2012. The theme, “A Future Free of Lymphatic Filariasis: Reaching the Vision by Scaling Up, Scaling Down and Reaching Out”, emphasized new strategies and partnerships necessary to reach the 2020 goal of elimination of lymphatic filariasis (LF) as a public-health problem.
GAELFreport (1.32 MB)WHO Guide
Lymphatic Filariasis: Managing Morbidity and Preventing Disability
Guide on planning, implementing and monitoring activities at national level. This guide provides the best available information on managing morbidity and preventing disability after acute dermatolymphangioadenitis (ADLA; acute attacks), lymphoedema or elephantiasis, and hydrocoele.